PLIANT THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-22.4M | $-20.0M | $-26.3M | $-43.3M | $-56.2M | $-57.8M | $-55.9M | $-47.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $200.0K | $264.0K | $400.0K | $400.0K | $448.0K | $500.0K | $600.0K | $513.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $4.3M | — | — | $8.9M | — | — | $9.7M |
| Net Cash from Operating Activities | $-12.8M | $-19.2M | $-21.1M | $-40.6M | $-48.9M | $-32.3M | $-45.3M | $-30.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $0 | $112.0K | $262.0K | $896.0K | $1.3M | $1.5M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-4.1M | — | — | $69.1M | — | — | $59.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $74.0K | — | — | $498.0K | — | — | $21.8M |
| Net Change in Cash | — | $-23.3M | — | — | $20.7M | — | — | $51.1M |
| Free Cash Flow | $-12.8M | $-19.2M | $-21.1M | $-40.7M | $-49.1M | $-33.2M | $-46.5M | $-31.8M |